Letter by sullivan et al regarding article, "lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland"

Circulation

Volumn 121, Issue 14, 2010, Pages

  Sullivan, Jerome L ^a   Bailey, Damian Miles ^b   Zacharski, Leo R ^c  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GLAMORGAN   (United Kingdom)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEPCIDIN; HYPOXIA INDUCIBLE FACTOR; IRON;

ALTITUDE; CARDIOVASCULAR DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SWITZERLAND;

ALTITUDE; CARDIOTONIC AGENTS; CORONARY DISEASE; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IRON; MENSTRUATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; STROKE; SWITZERLAND;

EID: 77950921343     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3181dab7d5     Document Type: Letter

References (5)

1. Faeh D, Gutzwiller F, Bopp M. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009; 120:495-501.
2. Sullivan JL. Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis. Am Heart J. 2003;145:190-194.
3. Robach P, Cairo G, Gelfi C, Bernuzzi F, Pilegaard H, Vigano A, Sant-ambrogio P, Cerretelli P, Calbet JAL, Moutereau S, Lundby C. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle. Blood. 2007;109:4724-4731.
4. Sullivan J. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med. 2007;232:1014-1020.
5. Valenti L, Swinkels DW, Burdick L, Tjalsma H, Bertelli C, Fatta C, Bignamini D, Dongiovanni P, Rametta R, Motta BM, Fargion S, Fra-canzani AL. Serum ferritin and hepcidin levels predict vascular damage in patients with nonalcoholic fatty liver disease. Am J Hematol. 2009;84: E236-E375.